Literature DB >> 9037299

Fulminant hepatic failure associated with bicalutamide.

L A Dawson1, E Chow, G Morton.   

Abstract

Bicalutamide is a new, nonsteroidal antiandrogen with a favorable toxicity profile. We report the first case of fulminant hepatic failure associated with its use.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9037299     DOI： 10.1016/S0090-4295(96)00355-X

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  5 in total

1.  Drug-related hepatotoxicity and hepatic failure following combined androgen blockade.

Authors:  Inmaculada Castro Beza; Jesús Sánchez Ruiz; Francisco José Peracaula Espino; M Isabel Villanego Beltrán
Journal:  Clin Transl Oncol       Date:  2008-09       Impact factor: 3.405

Review 2.  Bicalutamide in advanced prostate cancer. A review.

Authors:  K L Goa; C M Spencer
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

3.  Atypical onset of bicalutamide-induced liver injury.

Authors:  Gee Young Yun; Seok Hyun Kim; Seok Won Kim; Jong Seok Joo; Ju Seok Kim; Eaum Seok Lee; Byung Seok Lee; Sun Hyoung Kang; Hee Seok Moon; Jae Kyu Sung; Heon Young Lee; Kyung Hee Kim
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

4.  Microscopic polyangiitis complicated by the development of prostate cancer and flutamide-induced hepatitis.

Authors:  D Papaioannides; P Korantzopoulos; C Bouropoulos; P Latsi; M Fotinou; D Orphanidou
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.266

5.  Bicalutamide-induced hepatotoxicity: A rare adverse effect.

Authors:  Salwa Hussain; Abdallah Haidar; Robert E Bloom; Nafea Zayouna; Michael H Piper; Syed-Mohammed R Jafri
Journal:  Am J Case Rep       Date:  2014-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.